APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Human Combination Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Human Combination Vaccines Industry Growth and Trends Forecast to 2032

Report ID 173999600122 December 202593 pages

Choose your research edition.

Industry ResearchHuman Combination Vaccines Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Combination Vaccines Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Human Combination Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Combination Vaccines Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Combination Vaccines Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Human Combination Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Combination Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Combination Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Combination Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Combination Vaccines include Takeda Pharmaceuticals, Sanofi, Merck, GlaxoSmithKline, Serum Institute of India and Daiichi Sankyo, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Combination Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Combination Vaccines market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Combination Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Combination Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Combination Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Combination Vaccines Market by Company

Takeda Pharmaceuticals

Sanofi

Merck

GlaxoSmithKline

Serum Institute of India

Daiichi Sankyo

Human Combination Vaccines Segment by Type

Human Combination Inactivated Vaccines

Human Combination Live Attenuated Vaccines

Human Combination Vaccines Segment by Application

Hospitals

Clinics

Others

Human Combination Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Combination Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Combination Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Combination Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Combination Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Combination Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Human Combination Inactivated Vaccines Table 2. Major Company of Human Combination Live Attenuated Vaccines Table 3. Global Human Combination Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Human Combination Vaccines Sales by Type (2021-2026) & (k units) Table 5. Global Human Combination Vaccines Sales Market Share in Volume by Type (2021-2026) Table 6. Global Human Combination Vaccines Sales by Type (2021-2026) & (US$ Million) Table 7. Global Human Combination Vaccines Sales Market Share in Value by Type (2021-2026) Table 8. Global Human Combination Vaccines Price by Type (2021-2026) & (US$/unit) Table 9. Global Human Combination Vaccines Sales by Type (2027-2032) & (k units) Table 10. Global Human Combination Vaccines Sales Market Share in Volume by Type (2027-2032) Table 11. Global Human Combination Vaccines Sales by Type (2027-2032) & (US$ Million) Table 12. Global Human Combination Vaccines Sales Market Share in Value by Type (2027-2032) Table 13. Global Human Combination Vaccines Price by Type (2027-2032) & (US$/unit) Table 14. North America Human Combination Vaccines Sales by Type (2021-2026) & (k units) Table 15. North America Human Combination Vaccines Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Human Combination Vaccines Sales by Type (2021-2026) & (k units) Table 17. Europe Human Combination Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Human Combination Vaccines Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Human Combination Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Human Combination Vaccines Sales by Type (2021-2026) & (k units) Table 21. Latin America Human Combination Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Human Combination Vaccines Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Human Combination Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Human Combination Vaccines Industry Trends Table 25. Human Combination Vaccines Industry Drivers Table 26. Human Combination Vaccines Industry Opportunities and Challenges Table 27. Human Combination Vaccines Industry Restraints Table 28. Global Human Combination Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Human Combination Vaccines Revenue Market Share by Company (2021-2026) Table 30. Global Human Combination Vaccines Sales by Company (2021-2026) & (k units) Table 31. Global Human Combination Vaccines Sales Share by Company (2021-2026) Table 32. Global Human Combination Vaccines Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Human Combination Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Human Combination Vaccines Major Company Production Sites and Headquarters Table 35. Global Human Combination Vaccines Company, Product Type & Application Table 36. Global Human Combination Vaccines Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Human Combination Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Human Combination Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Human Combination Vaccines Sales by Region (2021-2026) & (k units) Table 41. Global Human Combination Vaccines Sales Market Share in Volume by Region (2021-2026) Table 42. Global Human Combination Vaccines Sales by Region (2021-2026) & (US$ Million) Table 43. Global Human Combination Vaccines Sales Market Share in Value by Region (2021-2026) Table 44. Global Human Combination Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Human Combination Vaccines Sales by Region (2027-2032) & (k units) Table 46. Global Human Combination Vaccines Sales Market Share in Volume by Region (2027-2032) Table 47. Global Human Combination Vaccines Sales by Region (2027-2032) & (US$ Million) Table 48. Global Human Combination Vaccines Sales Market Share in Value by Region (2027-2032) Table 49. Global Human Combination Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Human Combination Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Human Combination Vaccines Sales by Application (2021-2026) & (k units) Table 52. Global Human Combination Vaccines Sales Market Share in Volume by Application (2021-2026) Table 53. Global Human Combination Vaccines Sales by Application (2021-2026) & (US$ Million) Table 54. Global Human Combination Vaccines Sales Market Share in Value by Application (2021-2026) Table 55. Global Human Combination Vaccines Price by Application (2021-2026) & (US$/unit) Table 56. Global Human Combination Vaccines Sales by Application (2027-2032) & (k units) Table 57. Global Human Combination Vaccines Sales Market Share in Volume by Application (2027-2032) Table 58. Global Human Combination Vaccines Sales by Application (2027-2032) & (US$ Million) Table 59. Global Human Combination Vaccines Sales Market Share in Value by Application (2027-2032) Table 60. Global Human Combination Vaccines Price by Application (2027-2032) & (US$/unit) Table 61. North America Human Combination Vaccines Sales by Application (2021-2026) & (k units) Table 62. North America Human Combination Vaccines Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Human Combination Vaccines Sales by Application (2021-2026) & (k units) Table 64. Europe Human Combination Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Human Combination Vaccines Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Human Combination Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Human Combination Vaccines Sales by Application (2021-2026) & (k units) Table 68. Latin America Human Combination Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Human Combination Vaccines Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Human Combination Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. Takeda Pharmaceuticals Company Information Table 72. Takeda Pharmaceuticals Business Overview Table 73. Takeda Pharmaceuticals Human Combination Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Takeda Pharmaceuticals Human Combination Vaccines Product Portfolio Table 75. Takeda Pharmaceuticals Recent Development Table 76. Sanofi Company Information Table 77. Sanofi Business Overview Table 78. Sanofi Human Combination Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Sanofi Human Combination Vaccines Product Portfolio Table 80. Sanofi Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck Human Combination Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Merck Human Combination Vaccines Product Portfolio Table 85. Merck Recent Development Table 86. GlaxoSmithKline Company Information Table 87. GlaxoSmithKline Business Overview Table 88. GlaxoSmithKline Human Combination Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. GlaxoSmithKline Human Combination Vaccines Product Portfolio Table 90. GlaxoSmithKline Recent Development Table 91. Serum Institute of India Company Information Table 92. Serum Institute of India Business Overview Table 93. Serum Institute of India Human Combination Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Serum Institute of India Human Combination Vaccines Product Portfolio Table 95. Serum Institute of India Recent Development Table 96. Daiichi Sankyo Company Information Table 97. Daiichi Sankyo Business Overview Table 98. Daiichi Sankyo Human Combination Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Daiichi Sankyo Human Combination Vaccines Product Portfolio Table 100. Daiichi Sankyo Recent Development Table 101. North America Human Combination Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 102. North America Human Combination Vaccines Sales by Country (2021-2026) & (k units) Table 103. North America Human Combination Vaccines Sales Market Share by Country (2021-2026) Table 104. North America Human Combination Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 105. North America Human Combination Vaccines Sales Market Share Forecast by Country (2027-2032) Table 106. North America Human Combination Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Human Combination Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Human Combination Vaccines Market Share by Country (2021-2026) Table 109. North America Human Combination Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Human Combination Vaccines Market Share Forecast by Country (2027-2032) Table 111. Europe Human Combination Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 112. Europe Human Combination Vaccines Sales by Country (2021-2026) & (k units) Table 113. Europe Human Combination Vaccines Sales Market Share by Country (2021-2026) Table 114. Europe Human Combination Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 115. Europe Human Combination Vaccines Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Human Combination Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Human Combination Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Human Combination Vaccines Market Share by Country (2021-2026) Table 119. Europe Human Combination Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Human Combination Vaccines Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Human Combination Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Human Combination Vaccines Sales by Country (2021-2026) & (k units) Table 123. Asia-Pacific Human Combination Vaccines Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Human Combination Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 125. Asia-Pacific Human Combination Vaccines Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Human Combination Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Human Combination Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Human Combination Vaccines Market Share by Country (2021-2026) Table 129. Asia-Pacific Human Combination Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Human Combination Vaccines Market Share Forecast by Country (2027-2032) Table 131. Latin America Human Combination Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Latin America Human Combination Vaccines Sales by Country (2021-2026) & (k units) Table 133. Latin America Human Combination Vaccines Sales Market Share by Country (2021-2026) Table 134. Latin America Human Combination Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 135. Latin America Human Combination Vaccines Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Human Combination Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Human Combination Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Human Combination Vaccines Market Share by Country (2021-2026) Table 139. Latin America Human Combination Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Human Combination Vaccines Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Human Combination Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Human Combination Vaccines Sales by Country (2021-2026) & (k units) Table 143. Middle East and Africa Human Combination Vaccines Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Human Combination Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 145. Middle East and Africa Human Combination Vaccines Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Human Combination Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Human Combination Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Human Combination Vaccines Market Share by Country (2021-2026) Table 149. Middle East and Africa Human Combination Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Human Combination Vaccines Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Human Combination Vaccines Distributors List Table 154. Human Combination Vaccines Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Human Combination Vaccines Image Figure 2. Global Human Combination Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Combination Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Combination Vaccines Sales (2021-2032) & (k units) Figure 5. Human Combination Inactivated Vaccines Image Figure 6. Global Human Combination Inactivated Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 7. Human Combination Live Attenuated Vaccines Image Figure 8. Global Human Combination Live Attenuated Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Human Combination Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Human Combination Vaccines Market Share by Type 2025 VS 2032 Figure 11. North America Human Combination Vaccines Sales Market Share in Volume by Type in 2025 Figure 12. North America Human Combination Vaccines Sales Market Share in Value by Type in 2025 Figure 13. Europe Human Combination Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. Europe Human Combination Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Human Combination Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Human Combination Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Latin America Human Combination Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Human Combination Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Human Combination Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Human Combination Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Human Combination Vaccines Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospitals Image Figure 24. Global Hospitals Sales YoY Growth (2021-2032) & (k units) Figure 25. Clinics Image Figure 26. Global Clinics Sales YoY Growth (2021-2032) & (k units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Human Combination Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Human Combination Vaccines Market Share by Application 2025 VS 2032 Figure 31. North America Human Combination Vaccines Sales Market Share in Volume by Application in 2025 Figure 32. North America Human Combination Vaccines Sales Market Share in Value by Application in 2025 Figure 33. Europe Human Combination Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. Europe Human Combination Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Human Combination Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Human Combination Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Latin America Human Combination Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Human Combination Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Human Combination Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Human Combination Vaccines Sales Market Share in Value by Application in 2025 Figure 41. North America Human Combination Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Human Combination Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Human Combination Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Human Combination Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Human Combination Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Human Combination Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Human Combination Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Human Combination Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Human Combination Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Human Combination Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Human Combination Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Human Combination Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Human Combination Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Human Combination Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Human Combination Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Human Combination Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Human Combination Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Human Combination Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Human Combination Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Human Combination Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Human Combination Vaccines Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Human Combination Vaccines Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Human Combination Inactivated Vaccines
  • Human Combination Live Attenuated Vaccines
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Takeda Pharmaceuticals
  • Sanofi
  • Merck
  • GlaxoSmithKline
  • Serum Institute of India
  • Daiichi Sankyo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Combination Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Combination Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Combination Vaccines Market by Type
  6. 1.3.1 Human Combination Inactivated Vaccines
  7. 1.3.2 Human Combination Live Attenuated Vaccines
  8. 1.4 Global Human Combination Vaccines Market Size by Type
  9. 1.4.1 Global Human Combination Vaccines Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Human Combination Vaccines Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Human Combination Vaccines Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Human Combination Vaccines Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Human Combination Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Human Combination Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Human Combination Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Human Combination Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Combination Vaccines Industry Trends
  2. 2.2 Human Combination Vaccines Industry Drivers
  3. 2.3 Human Combination Vaccines Industry Opportunities and Challenges
  4. 2.4 Human Combination Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Combination Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Combination Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Human Combination Vaccines Price (2021-2026)
  4. 3.4 Global Human Combination Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Combination Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Human Combination Vaccines Company, Product Type & Application
  7. 3.7 Global Human Combination Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Combination Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Combination Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Combination Vaccines Tier 1, Tier 2, and Tier 3
4 Human Combination Vaccines Regional Status and Outlook
  1. 4.1 Global Human Combination Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Combination Vaccines Historic Market Size by Region
  3. 4.2.1 Global Human Combination Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Combination Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Combination Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Combination Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Human Combination Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Combination Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Combination Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Combination Vaccines by Application
  1. 5.1 Human Combination Vaccines Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Human Combination Vaccines Market Size by Application
  6. 5.2.1 Global Human Combination Vaccines Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Human Combination Vaccines Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Human Combination Vaccines Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Human Combination Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Human Combination Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Human Combination Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Human Combination Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Human Combination Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda Pharmaceuticals
  2. 6.1.1 Takeda Pharmaceuticals Company Information
  3. 6.1.2 Takeda Pharmaceuticals Business Overview
  4. 6.1.3 Takeda Pharmaceuticals Human Combination Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceuticals Human Combination Vaccines Product Portfolio
  6. 6.1.5 Takeda Pharmaceuticals Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Human Combination Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Human Combination Vaccines Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Human Combination Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Human Combination Vaccines Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 GlaxoSmithKline
  20. 6.4.1 GlaxoSmithKline Company Information
  21. 6.4.2 GlaxoSmithKline Business Overview
  22. 6.4.3 GlaxoSmithKline Human Combination Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GlaxoSmithKline Human Combination Vaccines Product Portfolio
  24. 6.4.5 GlaxoSmithKline Recent Developments
  25. 6.5 Serum Institute of India
  26. 6.5.1 Serum Institute of India Company Information
  27. 6.5.2 Serum Institute of India Business Overview
  28. 6.5.3 Serum Institute of India Human Combination Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Serum Institute of India Human Combination Vaccines Product Portfolio
  30. 6.5.5 Serum Institute of India Recent Developments
  31. 6.6 Daiichi Sankyo
  32. 6.6.1 Daiichi Sankyo Company Information
  33. 6.6.2 Daiichi Sankyo Business Overview
  34. 6.6.3 Daiichi Sankyo Human Combination Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Daiichi Sankyo Human Combination Vaccines Product Portfolio
  36. 6.6.5 Daiichi Sankyo Recent Developments
7 North America by Country
  1. 7.1 North America Human Combination Vaccines Sales by Country
  2. 7.1.1 North America Human Combination Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Combination Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Human Combination Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Combination Vaccines Market Size by Country
  6. 7.2.1 North America Human Combination Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Combination Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Combination Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Combination Vaccines Sales by Country
  2. 8.1.1 Europe Human Combination Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Combination Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Combination Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Combination Vaccines Market Size by Country
  6. 8.2.1 Europe Human Combination Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Combination Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Combination Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Combination Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Human Combination Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Combination Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Combination Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Combination Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Human Combination Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Combination Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Combination Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Combination Vaccines Sales by Country
  2. 10.1.1 South America Human Combination Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Combination Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Human Combination Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Combination Vaccines Market Size by Country
  6. 10.2.1 South America Human Combination Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Combination Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Combination Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Combination Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Human Combination Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Combination Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Combination Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Combination Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Human Combination Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Combination Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Combination Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Combination Vaccines Value Chain Analysis
  2. 12.1.1 Human Combination Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Combination Vaccines Production Mode & Process
  7. 12.2 Human Combination Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Combination Vaccines Distributors
  10. 12.2.3 Human Combination Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst